Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-RAD: Dexmedetomidine for Heart Rate Control in Rapid Atrial Fibrillation
NCT04042727Phase 3Terminated
- Sponsor
- Stony Brook University
- Start
- Aug 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in Atrial fibrillation (AFib), sponsored by Stony Brook University. Started Aug 2019; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04042727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042727.